Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Only 9% of patients on liragultide versus 36% of patients on placebo had progression of fibrosis
Rosenstock J, Buse JB, Azeem R, Prabhakar P, Kjems L, Huang H, et al
Wegovy may not be suitable for all individuals
Indication context: Semaglutide injection is FDA-approved under brand names Ozempic (type 2 diabetes, CV risk reduction) and Wegovy (chronic weight management, obesity or overweight with 1 weight-related comorbidity)
US$ 27.28
US$ 25.18
US$ 26.69
US$ 29.56
US$ 27.64
US$ 23.11
US$ 26.80
US$ 25.69
US$ 25.49
US$ 26.48
US$ 25.36
US$ 25.41
